Navigation Links
Authernative Awarded GSA Schedule Contract
Date:6/16/2008

REDWOOD CITY, Calif., June 16 /PRNewswire/ -- Authernative, Inc., a leading developer of innovative user authentication and identity management technologies, announced today that it has been awarded its General Services Administration (GSA) Information Technology Schedule contract, number GS-35F-0440U. The contract enables Authernative to sell its AuthGuard(R) user authentication product directly to government agencies.

The GSA Schedule contract, which represents Authernative's continued momentum in the federal government market, will make it easier for federal, state and local government entities to procure solutions from a trusted vendor and obtain already negotiated pricing that is determined to be "fair and reasonable" as well as at its "best value." Authernative remains committed to expanding and strengthening its government channel, recognizing this vertical market as an important factor for achieving its long-term growth.

The addition of Authernative to the GSA Schedule makes AuthGuard(R) user authentication solutions widely available to all federal customers while complying with government initiatives including "E-Authentication," "Protection of Agency Sensitive Information," "Safeguarding Personally Identifiable Information," "Telework," "Policy for a Common Identification Standard for Federal Employees and Contractors," "Continuity of Operations Programs," and other initiatives designed to ensure secure access in government environments.

The AuthGuard(R) solution stands out from other user authentication security products because of its versatile range of patented secure authentication methods that are provided in one product, together with the FIPS 140-2 validated Authernative(R) Cryptographic Module, and self-service capabilities. AuthGuard(R) authentication options range from legacy password, to one-time challenge one-time response, OTP, out-of-band and secure in-band authentication. These methods, used alone or in combinatio
'/>"/>

SOURCE Authernative, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology news :

1. 12 McGill researchers awarded Canada Research Chairs
2. Anthony S. Fauci awarded Lasker Award for Public Service
3. ETH Zurich professor Ari Helenius awarded Benoist Prize
4. Nanobiosym awarded $2 million DTRA contract
5. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
6. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
7. $2.7 million awarded for metastatic colon cancer research
8. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
9. BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh
10. University awarded £5M to investigate how cells communicate
11. Manomet Center awarded major NFWF grant to foster shorebird conservation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...olar panels that repels grime and dirt? Expanded b...r? New Tel Aviv University research, just publishe...gh in assembling peptides at the nano-scale level ... in just a few years. , Operating in the range o...) and even smaller, graduate student Lihi Adler-Ab...
(Date:12/3/2009)... a personality change in warmer water, according t...change may make some species more aggressive. , ...n Australia,s Great Barrier Reef have shown for th...tently timid, or consistently bold, and that these...ter temperatures rise. , A slight lift of just o...
(Date:12/3/2009)...ists from the U.S. Department of Energy,s (DOE) Br...and the Indian Institute of Science has made a maj...genetic information in DNA that is necessary to ca...ch, published in the December 1, 2009 edition of ...hat many proteins responsible for interacting at s...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 1Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 2Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 3Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 4Long Term Care 3A The Next Big Womens Issue 3F 51873 1Long Term Care 3A The Next Big Womens Issue 3F 51873 2Sinovac Adjourns 2008 Annual General Meeting 13056 1Sinovac Adjourns 2008 Annual General Meeting 13056 2
... The General Services Administration (GSA) has cer... a provider of Personal Identity Verification (PIV...managed services, under Homeland Security Presiden...on, ABBTECH will offer services through their GSA ...n approved service provider. Services provided b...
...l 3, 2009 -- By identifying a novel compound that ... Ridge National Laboratory and the University of C...stant plants. , In a paper published in Science ...artment of Energy,s ORNL reports that azelaic acid...abidopsis, a small flowering plant related to cabb...
...itor of Playboy magazine, has won the 2009 Media A...ces (AIBS), given to a journalist for outstanding ...r broadcast journalism. Rowe,s story, "Sexual Male... the magazine on scientists, findings during the p...lopment. This segment of the series appeared in th...
Other Biology News:ABBTECH Staffing Services Certified by GSA as an HSPD-12 Managed Service Provider 2Researchers discover primer to plant defense system 22009 AIBS Media Award 22009 AIBS Media Award 3
(Date:12/3/2009)..., , PHILADELPHIA, Dec. 3 /PRNewswire-Fir...the global specialty biopharmaceutical company, to...voluntary market withdrawal of one lot of the Atte...Daytrana ® . Shire is taking this action beca...ture may not meet their release liner removal spec...
(Date:12/3/2009)..., , NEW DELHI, India, Dec. 3 ...,Chief Science Officer at Shenzhen Beike Biotechno...oke at a conference on High-Risk Diabetic,Foot Car... China,s leading,stem cell research and regenerati...ganized by the Indian Podiatry Association (IPA), ...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ ...search report is available in its catalogue: ,,...ective ,, http://www.reportlinker.com/p016436...ective.html ,, Incubators are the most critic...r, research, and other applications for providing ...
(Date:12/2/2009)..., , TUSTIN, Calif., Dec. 2 /PRNewswire...sdaq: PPHM ) today reported completion of patient...rial of Cotara® in patients with relapsed gli...brain cancer. Cotara is a targeted monoclonal ant...a potential new treatment for GBM. Cotara specifi...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...sdaq: FOLD ) will announce third quarter 2008 fin...on Monday, November 3, 2008. The results,announcem... webcast that,afternoon at 5 p.m. ET., Interested...nce call at,5 p.m. ET by dialing 877-419-6591 (U.S...honic replay of the call will be available for,sev...
...Eastern Time Today to D...st,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today an... intravenous (i.v.) peramivir, a neuraminidase,inh... or potentially,life-threatening influenza. The Ph...ve days of therapy with either 200 mg i.v. peramiv...
...tivities, enhancement in research investment from ...of user-friendly products is likely to propel the ...tic and manual, to reach $315 million by 2015. , ...B) October 27, 2008 -- Titration is one of the mos...he chemical composition of laboratory and industri...
Other Biology Technology:Amicus Therapeutics Announces Third Quarter 2008 Results Release Date 2BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 2BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 3BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 4BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 5BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 6Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc. 2Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc. 3
...98C679.2.1] to Presenilin 2 Alzheimer's disease (... carry mutations in the presenilin proteins (PSEN1...hese disease-linked mutations result in increased ...n component of amyloid deposits found in AD brains...
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Goat Anti-Human Glypican 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Beta 2-Microglobulin ELISA Kit from Biomeda Corporation
Biology Products: